Document Detail


Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
MedLine Citation:
PMID:  8703666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) have pulmonary vasorelaxant activity with plasma concentrations being elevated in patients with hypoxaemic pulmonary hypertension. However, their effects on acute hypoxic pulmonary vasoconstriction (HPV), the initiating stimulus for pulmonary hypertension have not to date been investigated. We have therefore studied the effects of ANP and BNP on acute HPV in humans. 2. Eight healthy volunteers were studied on three separate occasions. After reaching a resting haemodynamic state (t0), an infusion of either ANP (10 pmol kg-1 min-1), BNP (10 pmol kg-1 min-1) or placebo (5% dextrose) was commenced. This was given alone for 30 min (t30) before subjects were rendered hypoxaemic (SaO2 75-80%) for a further 30 min (t60), with the initial infusion continuing to t60. Pulsed-wave Doppler analysis of pulmonary artery flow was used to measure mean pulmonary arterial pressure (MPAP) and hence total pulmonary vascular resistance (PVR) was calculated. 3. MPAP and PVR both tended to decrease in response to ANP and BNP infusion, although compared with placebo, the difference at t30 was only statistically significant for PVR. Hypoxaemia increased MPAP and PVR, although values at t60 were significantly lower following both ANP and BNP compared with placebo. 4. In terms of the actual change in PVR (delta PVR) induced by hypoxaemia (from t30 to t60), BNP (146(16) dyn s cm-5), but not ANP (183(21) dyn s cm-5) significantly attenuated delta PVR compared with placebo (194(26) dyns s cm-5): mean difference BNP versus placebo 48 dyn s cm-5, 95% Cl 3-93. An identical pattern was observed for delta MPAP where BNP (15.9(1.1) mmHg), but not ANP (18.0(1.2) mmHg) significantly attenuated delta MPAP compared with placebo (19.0(1.7) mmHg): mean difference BNP versus placebo 3.1 mmHg, 95% Cl 0.7-5.5. 5. Thus, although both ANP and BNP exhibit pulmonary vasorelaxant activity, only BNP significantly attenuated the MPAP and PVR responses to acute hypoxaemia. This suggests that the natriuretic peptides may have a role in attenuating pulmonary hypertension secondary to hypoxaemia.
Authors:
R I Cargill; B J Lipworth
Related Documents :
15337836 - Effects of cardiac hormones on arterial pressure and sodium excretion in npra knockout ...
22327726 - Spontaneous cortical spreading depression and intracranial pressure following acute sub...
15129786 - Determinants of left atrial pressure in rheumatic mitral stenosis: role of left atrial ...
2527656 - Atrial natriuretic peptide levels in congestive heart failure in man before and during ...
15235976 - Evaluation of conventional weaning criteria in patients with acute respiratory failure.
1383836 - Cp-96,345, a non-peptide antagonist of substance p. iii. cardiovascular effects in mamm...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  40     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1995 Dec 
Date Detail:
Created Date:  1996-09-09     Completed Date:  1996-09-09     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  585-90     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology, Ninewells Hospital and Medical School, University of Dundee, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anoxia / classification,  physiopathology*
Atrial Natriuretic Factor / pharmacology*
Humans
Lung / blood supply*
Male
Natriuretic Peptide, Brain
Nerve Tissue Proteins / pharmacology*
Vasoconstriction / drug effects*
Chemical
Reg. No./Substance:
0/Nerve Tissue Proteins; 114471-18-0/Natriuretic Peptide, Brain; 85637-73-6/Atrial Natriuretic Factor
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers.
Next Document:  The effect of HN-65021 on responses to angiotensin II in human forearm vasculature.